JP2020521490A5 - - Google Patents

Download PDF

Info

Publication number
JP2020521490A5
JP2020521490A5 JP2019566198A JP2019566198A JP2020521490A5 JP 2020521490 A5 JP2020521490 A5 JP 2020521490A5 JP 2019566198 A JP2019566198 A JP 2019566198A JP 2019566198 A JP2019566198 A JP 2019566198A JP 2020521490 A5 JP2020521490 A5 JP 2020521490A5
Authority
JP
Japan
Prior art keywords
antigen
antibody
seq
sequence defined
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019566198A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020521490A (ja
JP7460370B2 (ja
Filing date
Publication date
Priority claimed from GBGB1708655.4A external-priority patent/GB201708655D0/en
Application filed filed Critical
Publication of JP2020521490A publication Critical patent/JP2020521490A/ja
Priority to JP2021141016A priority Critical patent/JP7560420B2/ja
Publication of JP2020521490A5 publication Critical patent/JP2020521490A5/ja
Priority to JP2022109106A priority patent/JP7406593B2/ja
Application granted granted Critical
Publication of JP7460370B2 publication Critical patent/JP7460370B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019566198A 2017-05-31 2018-05-29 細胞培養方法 Active JP7460370B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021141016A JP7560420B2 (ja) 2017-05-31 2021-08-31 細胞培養方法
JP2022109106A JP7406593B2 (ja) 2017-05-31 2022-07-06 細胞培養方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1708655.4 2017-05-31
GBGB1708655.4A GB201708655D0 (en) 2017-05-31 2017-05-31 Cell culture methods
PCT/EP2018/064102 WO2018219968A1 (en) 2017-05-31 2018-05-29 Cell culture methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021141016A Division JP7560420B2 (ja) 2017-05-31 2021-08-31 細胞培養方法

Publications (3)

Publication Number Publication Date
JP2020521490A JP2020521490A (ja) 2020-07-27
JP2020521490A5 true JP2020521490A5 (cg-RX-API-DMAC10.html) 2022-06-16
JP7460370B2 JP7460370B2 (ja) 2024-04-02

Family

ID=59270991

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019566198A Active JP7460370B2 (ja) 2017-05-31 2018-05-29 細胞培養方法
JP2021141016A Active JP7560420B2 (ja) 2017-05-31 2021-08-31 細胞培養方法
JP2022109106A Active JP7406593B2 (ja) 2017-05-31 2022-07-06 細胞培養方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021141016A Active JP7560420B2 (ja) 2017-05-31 2021-08-31 細胞培養方法
JP2022109106A Active JP7406593B2 (ja) 2017-05-31 2022-07-06 細胞培養方法

Country Status (21)

Country Link
US (3) US12077796B2 (cg-RX-API-DMAC10.html)
EP (2) EP3630946B1 (cg-RX-API-DMAC10.html)
JP (3) JP7460370B2 (cg-RX-API-DMAC10.html)
KR (3) KR102975392B1 (cg-RX-API-DMAC10.html)
CN (2) CN110741077B (cg-RX-API-DMAC10.html)
AU (2) AU2018276376C1 (cg-RX-API-DMAC10.html)
BR (1) BR112019024390A2 (cg-RX-API-DMAC10.html)
CA (1) CA3065661A1 (cg-RX-API-DMAC10.html)
CL (1) CL2019003459A1 (cg-RX-API-DMAC10.html)
CO (1) CO2019012871A2 (cg-RX-API-DMAC10.html)
EA (1) EA201992828A1 (cg-RX-API-DMAC10.html)
ES (1) ES2978394T3 (cg-RX-API-DMAC10.html)
GB (1) GB201708655D0 (cg-RX-API-DMAC10.html)
HR (1) HRP20240585T1 (cg-RX-API-DMAC10.html)
HU (1) HUE066922T2 (cg-RX-API-DMAC10.html)
IL (2) IL317828A (cg-RX-API-DMAC10.html)
MX (1) MX2019014140A (cg-RX-API-DMAC10.html)
MY (1) MY193535A (cg-RX-API-DMAC10.html)
PL (1) PL3630946T3 (cg-RX-API-DMAC10.html)
RU (2) RU2758674C2 (cg-RX-API-DMAC10.html)
WO (1) WO2018219968A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201708655D0 (en) * 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
CN116635416A (zh) * 2020-12-22 2023-08-22 诺华股份有限公司 用于在细胞培养期间降低分泌的重组表达蛋白质中半胱氨酸残基的氧化水平的方法
GB202105424D0 (en) * 2021-04-16 2021-06-02 UCB Biopharma SRL Cell culture processes
WO2025262319A1 (en) 2024-06-21 2025-12-26 Boehringer Ingelheim International Gmbh Modifying blue color formation in bioprocesses

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672502A (en) 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
US6048728A (en) 1988-09-23 2000-04-11 Chiron Corporation Cell culture medium for enhanced cell growth, culture longevity, and product expression
EP2221361A3 (en) 1996-08-30 2011-02-09 Life Technologies Corporation Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
US20030138417A1 (en) 2001-11-08 2003-07-24 Kaisheva Elizabet A. Stable liquid pharmaceutical formulation of IgG antibodies
DE602004027905D1 (de) 2003-05-15 2010-08-12 Wyeth Llc Kontrollierte glukosezufuhr für tierzellkultur
US7335491B2 (en) 2004-08-27 2008-02-26 Wyeth Research Ireland Limited Production of anti-abeta
US7300773B2 (en) 2004-08-27 2007-11-27 Wyeth Research Ireland Limited Production of TNFR-Ig
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
MX2009004974A (es) 2006-11-08 2009-05-20 Wyeth Corp Medios diseñado racionalmente para cultivo celular.
US8030027B2 (en) * 2008-04-29 2011-10-04 St. Jude Children's Research Hospital Method for enhancing recombinant antibody production
JP5749930B2 (ja) 2008-10-28 2015-07-15 中外製薬株式会社 ペプチド含有動物細胞培養用培地
US20110262965A1 (en) 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
CN102858953B (zh) 2010-04-26 2015-09-09 诺瓦提斯公司 改进的细胞培养基
LT2563906T (lt) 2010-04-26 2018-02-26 Novartis Ag Cho ląstelių kultivavimo būdas
CN102653729B (zh) 2011-03-04 2014-07-16 上海赛金生物医药有限公司 一种用于中国仓鼠卵巢细胞的培养基
US9133493B2 (en) * 2011-04-21 2015-09-15 Amgen Inc. Method for culturing mammalian cells to improve recombinant protein production
JP6265970B2 (ja) 2012-03-26 2018-01-24 サノフイ 安定なIgG4に基づく結合剤の製剤
WO2013158275A1 (en) * 2012-04-20 2013-10-24 Abbvie Inc. Cell culture methods to reduce acidic species
US20130281355A1 (en) 2012-04-24 2013-10-24 Genentech, Inc. Cell culture compositions and methods for polypeptide production
GB201208367D0 (en) * 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
GB201208370D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Antibodies
CA2903589A1 (en) 2013-03-15 2014-09-18 Genentech, Inc. Cell culture media and methods of antibody production
BR112016027797A2 (pt) 2014-06-18 2017-10-31 Medimmune Llc métodos e meios de cultura de células compreendendo n-acetilcisteína
KR20170100074A (ko) 2014-12-29 2017-09-04 완롭 위롯페이싯 상승된 전압 및 향상된 장착 방식을 구비한 엔진 연소시스템의 산소효율 증진장치
GB201508180D0 (en) * 2015-05-13 2015-06-24 Ucb Biopharma Sprl Antibodies
SG11201809408SA (en) * 2016-04-28 2018-11-29 Merck Patent Gmbh Method for reducing the trisulfide level in proteins
GB201608323D0 (en) * 2016-05-12 2016-06-29 Ucb Biopharma Sprl Pharmaceutical compositions
WO2018018613A1 (zh) * 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
CN106222129A (zh) 2016-07-29 2016-12-14 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
GB201708655D0 (en) * 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods

Similar Documents

Publication Publication Date Title
JP2024009962A5 (cg-RX-API-DMAC10.html)
JP2022523442A5 (cg-RX-API-DMAC10.html)
AR040046A1 (es) Anticuerpo neutralizante humano anti-igfr
JP2021094022A5 (cg-RX-API-DMAC10.html)
JP2022122865A5 (cg-RX-API-DMAC10.html)
HRP20110187T1 (hr) Multispecifične deimunizirane tvari koje vežu cd3
CA3166139C (en) Engineered anti-il-2 antibodies
RU2012118636A (ru) Молекула, специфически связывающаяся с rsv
JP2021503938A5 (cg-RX-API-DMAC10.html)
JP7560420B2 (ja) 細胞培養方法
HRP20231175T1 (hr) Postupci kultiviranja stanica
JP2024544523A5 (cg-RX-API-DMAC10.html)
JP2024546759A5 (cg-RX-API-DMAC10.html)
JP2021185185A5 (cg-RX-API-DMAC10.html)
EP4628095A1 (en) Fusion protein and granulated antigen comprising same
JP2024509701A5 (cg-RX-API-DMAC10.html)
JP2023507280A5 (cg-RX-API-DMAC10.html)
JP2025537544A5 (ja) 融合タンパク質及びそれを含む粒子状抗原
EP4458856A1 (en) Method for producing anti-egfr antibody, method for improving affinity for fc gamma riiia, and anti-egfr antibody
CN115551877A (zh) 组合物和方法
JP2023505219A5 (cg-RX-API-DMAC10.html)
RU2024139604A (ru) Антитела к bcma
RU2026105457A (ru) Антитела к белку а-бета, способы и их применения
JP2026062918A5 (cg-RX-API-DMAC10.html)
JP2024534853A5 (cg-RX-API-DMAC10.html)